Worth Venture Partners, LLC Insmed Inc Put Options Transaction History

Worth Venture Partners, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 15, 2019	SELL	$11.6 - $18.7 $886,240 - $1.43 Million	-76,400 Closed	0 $0
Q3 2018 Nov 15, 2018	SELL	$18.95 - $28.08 $333,520 - $494,207	-17,600 Reduced 18.72%	76,400 $178,000
Q2 2018 Aug 13, 2018	BUY	$20.0 - $29.72 $1.65 Million - $2.45 Million	82,300 Added 703.42%	94,000 $217,000
Q1 2018 May 25, 2018	SELL	$21.69 - $32.99 $25.1 Million - $38.2 Million	-1,158,300 Reduced 99.0%	11,700 $26,000
Q1 2018 May 11, 2018	BUY	$21.69 - $32.99 $25.4 Million - $38.6 Million	1,170,000 New	1,170,000 $26,000
Q4 2017 Feb 01, 2018	SELL	$26.43 - $31.78 $1.23 Million - $1.48 Million	-46,500 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$11.61 - $31.21 $539,865 - $1.45 Million	46,500	46,500 $3,000

484

182M

2.14M

3.25M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.